James N. Kochenderfer

2 ta ish

National Cancer Institute

1. Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

   Noopur Raje, Jesús G. Berdeja, Yi Lin +20

   MaqolaOAOchiq kirish20195 iqtibos

   ABIABI:AkademIndex/2026.other.082848

2. Long-term outcomes following CAR T cell therapy: what we know so far

   Kathryn M. Cappell, James N. Kochenderfer

   Sharh maqolaOAOchiq kirish20233 iqtibos

   ABIABI:AkademIndex/2026.other.102938